GAVI's evaluation studies

This report presents the findings and lessons from an evaluation of the GAVI-Government of China Hepatitis B vaccination programme. The evaluation was conducted in 2012 by Abt Associates.

This report presents the findings and lessons from an evaluation of the GAVI Gender Policy. The evaluation was conducted in 2012 by ICF Macro, Inc.

This report presents the findings of the Process and Design Evaluation for the Pilot Advance Market Commitment (AMC) for Pneumococcal Vaccines. This evaluation was conducted in 2012 by Dalberg Global Development Advisors.

This report presents the findings and lessons learnt from a review of GAVI support to civil society organisations undertaken by Cambridge Economic Policy Associates.

This report presents the findings and lessons learnt from a review of the AVI project undertaken by Cambridge Economic Policy Associates for GAVI.

Study of whether IFF concept is proven and whether IFFIm pilot has worked (published 2011).

The Baseline Study for the pneumococcal vaccine Advance Market Commitment establishes the environment prior to the AMC as a basis for future evaluations.

Independent assessment of the Alliance's achievements in GAVI Phase II (published 2010).

Assessing design, execution and results of Independent Review Committees (published 2010).

Study covers 21 countries where HSS had been rolled out by December 2008 (published 2009).

Complements HSS study; highlights implementation issues in six countries (published 2009).

Analysis of sustainability of injection safety support in 58 countries (published 2008).

Independent assessment of the Alliance’s achievements in GAVI Phase I (published 2009).

Effectiveness of immunisation services support over its first five years (published 2007).

Reviewing special initiatives to accelerate introduction of new vaccines (published 2007).